Aug 20, 2019

Bayer agrees to sell its veterinary drugs business to Elanco

Dan Primack, author of Pro Rata

A dog standing next to animal medication produced by Elanco. Photo: Frank Rumpenhorst/AFP/Getty Images

Bayer agreed to sell its veterinary drugs business to Elanco for $7.6 billion in cash and stock.

Why it matters: It creates the world's second-largest animal health company by revenue, behind Zoetis, with a 13% market share. It also will help Bayer cut into the debt pile it built via last year's Monsanto acquisition.

  • The bottom line: "Pfizer's decision to spin out its animal-health business, Zoetis, in 2013 has prodded other drugmakers to shed their veterinary units. The businesses are often stable, profitable operations whose fortunes are more tied to macroeconomic trends like rising global wealth and protein consumption, instead of risky bets on drug research," writes Bloomberg's Riley Griffin.

Go deeper

3 hours ago - Technology

The slippery slope of protest surveillance

Illustration: Aïda Amer/Axios

President Trump's call to treat antifa supporters like terrorists could be a green light for high-tech surveillance of dissidents.

Why it matters: It's unlikely the Trump administration can designate antifa as a terrorist group in any legally meaningful way, but the declaration gives law enforcement tacit approval to use a plethora of tech tools to monitor protesters and left-leaning activists.

The biggest crisis since 1968

Illustration: Aïda Amer/Axios. Photo: Bettmann/Contributor

The year 1968 has been on a lot of people’s minds lately — another year of protests, violence and upheaval that seemed to be tearing the nation apart.

Yes, but: This crisis also has moments we’ve never seen before — and some historians and experts say the differences suggest that 2020 doesn't compare well at all.

SoftBank to launch $100M fund backing companies led by people of color

Illustration: Aïda Amer/Axios

SoftBank COO Marcelo Claure said in a letter to employees early Wednesday that the firm will create a $100 million fund that "will only invest in companies led by founders and entrepreneurs of color."

Why it matters: The Opportunity Growth Fund is one of the first to put significant capital behind companies' statements of empathy and outrage in response to protests over systemic racism in the U.S. typified by the killings of George Floyd, Breonna Taylor and other African Americans by police.